The quality of life of parents of children with atopic dermatitis: Interpretation of PIQoL-AD scores

Quality of Life Research

Volumn 14, Issue 10, 2005, Pages 2235-2245

  Meads, D M ^a   McKenna, S P ^a   Kahler, K ^b  

^a GALEN RESEARCH   (United Kingdom)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Atopic dermatitis; Clinical significance; PIQoL AD; Quality of life; Questionnaire

Indexed keywords

PIMECROLIMUS;

ADULT; ARTICLE; ATOPIC DERMATITIS; CHILDHOOD DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INSTRUMENTATION; MALE; PARENT; PARENTS INDEX OF QUALITY OF LIFE IN ATOPIC DERMATITIS SCORING SYSTEM; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; STATISTICAL ANALYSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; HUMANS; MALE; PARENTS; QUALITY OF LIFE; QUESTIONNAIRES; UNITED STATES;

EID: 27944500708     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-005-5433-8     Document Type: Article

References (55)

1. L Papadopoulos R Bor 1999 Psychological Approaches to Dermatology BPS Books Leicester
2. U Pauli-Pott A Darui D Beckmann 1999 Infants with atopic dermatitis: Maternal hopelessness, child-rearing attitudes and perceived infant temperament Psychother Psychosom 68 39 45
3. AY Finlay 1992 Quality of life impairment in atopic dermatitis and psoriasis Clin Exp Perspect Sandimmum Ther 2 10 11
4. RSTC Barnetson M Rogers 2002 Childhood atopic eczema BMJ 324 1376 1379
5. LR Daud ME Garralda TJ David 1993 Psychosocial adjustment in preschool children with atopic eczema Arch Dis Child 69 670 676
6. BE Elliot K. Luker 1997 The experiences of mothers caring for a child with severe atopic eczema J Clin Nurs 6 241 247
7. AY Finlay 1998 Skin disease disability: Measuring its magnitude Keio J Med 47 131 134
8. V Lawson MS Lewis-Jones AY Finlay 1998 The family impact of childhood atopic dermatitis: The Dermatitis Family Impact Questionnaire Br J Dermatol 138 107 113
9. SP [tmp] McKenna D Whalley AL Dewar 2005 International development of the Parents' Index of Quality of Life in Atopic Dermatitis (PIQoL-AD) Qual Life Res 14 1 231 241
10. SM Hunt SP [tmp] McKenna 1992 The QLDS: A scale for the measurement of quality of life in depression Health Policy 22 307 319
11. V Ho S Hedgecock C Bush 2001 SDZ ASM 981 cream 1% efficacious and safe in infants aged 3-23 months with atopic eczema [abstract] J Eur Acad Dermatol Venereol 117 532
12. L Eichenfield A Lucky M, Boguniewicz 2002 Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of atopic dermatitis in children and adolescents J Am Acad Dermatol 46 495 504
13. A Kapp K Papp A, Bingham 2002 Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteriod anti-inflammatory drug J Allergy Clin Immunol 110 277 284
14. U Wahn JD Bos M Goodfield 2002 Efficacy and safety of pimecrolimus cream in the long-term management of atopic eczema in children Pediatrics 110 2 9
15. D Whalley J Huels SP [tmp] McKenna D Van Assche 2002 The benefit of pimecrolimus (Elidel, SDZ ASM 981) on parents' quality of life in the treatment of pediatric atopic dermatitis Pediatrics 110 6 1133 1136
16. PC Kendall 1999 Clinical significance J Consult Clin Psychol 67 283 354
17. T Symonds R Berzon P Marquis TA Rummans 2002 The clinical significance of quality-of-life results: Practical considerations for specific audiences [symposium on quality of life in cancer patients] Mayo Clin Proc 77 572 583
18. EG Lydick RS Epstein 1996 Clinical significance of quality of life data B Spilker Quality of Life and Pharmacoeconomics in Clinical Trials 2 Lippincott-Raven Philadelphia
19. GA Wells DE Beaton B, Shea 2001 Minimal clinically important differences: Review of methods J Rheumatol 28 406 412
20. GH Guyatt D Osoba A, Wu 2002 Methods to explain the clinical significance of health status measures; the clinical significance consensus meeting group Mayo Clin Proc 77 371 383
21. DE Beaton M Boers GA Wells 2002 Many faces of the minimal clinically important difference (MCID): A literature review and directions for future research Curr Opin Rheumatol 14 2 109 114
22. MH Liang RA Lew G Stucki PR Fortin L Daltroy 2002 Measuring clinically important changes with patient-oriented questionnaires Med Care 40 4 45 51
23. RD Crosby RL Kolotkin GR Williams 2003 Defining clinically meaningful change in health-related quality of life J Clin Epidemiol 56 395 407
24. LD [tmp] McLeod SE Fehnel J Brandman T Symonds 2003 Evaluating minimal clinically important differences for the acne-specific quality of life questionnaire Pharmacoeconomics 21 15 1069 1079
25. MH Erder N Santanello RD Hays 2003 Assessing the clinical significance of patient-reported outcomes: Examples drawn from a recent meeting of the Drug Information Association (DIA) Clin Ther 25 Supplement D12 D13
26. CJ Kelleher AM Pleil PR Reese SM Burgess PH Brodish 2004 How much is enough and who says so? The case of the King's Health Questionnaire and overactive bladder BJOG 111 605 612
27. D Cella EA Hahn K Dineen 2002 Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening Qual Life Res 11 207 221
28. EG Lydick BP Yawn 1998 Clinical interpretation of health-related quality of life data MJ Staquet RD Hays PM Fayers Quality of Life Assessment in Clinical Trials: Methods and Practice Oxford University Press Oxford
29. J Cohen 1977 Statistical Power Analysis for the Behavioural Sciences Academic Press New York
30. D Samsa G Edelman ML Rothman 1999 Determining clinically important differences in health status measures: A general approach with illustration to the Health Utilities Index Mark II Pharmacoeconomics 15 141 155
31. LE Kazis JJ Anderson RF Meenan 1989 Effect sizes for interpreting changes in health status Med Care 27 S178 S189
32. KW Wyrwich NA Nienaber WM Tierney FD Wolinsky 1999 Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life Med Care 37 5 469 478 May
33. A Anastasi S Urbina 1997 Psychological Testing, 7th ed Prentice Hall Upper Saddle River
34. JC Nunnally IH Bernstein 1994 Psychometric Theory McGraw Hill New York NY
35. KW Wyrwich WM Tierney FD Wolinsky 1999 Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life J Clin Epidemiol 52 9 861 873 Sep
36. KW Wyrwich WM Tierney FD Wolinsky 2002 Using the standard error of measurement to identify important changes on the Asthma Quality of Life Questionnaire Qual Life Res 11 1 1 7
37. HF Van Stel AR Maille VT Colland W Everaerd 2003 Interpretation of change and longitudinal validity of the quality of life for respiratory illness questionnaire (QoLQIQ) in in patient pulmonary rehabilitation Qual Life Res 12 133 145
38. R Fitzpatrick JM Norquist C Jenkinson 2004 Distribution-based criteria for change in health-related quality of lifein Parkinson's disease J Clinical Epidemiol 57 40 44
39. C [tmp] McHorney A Tarlov 1995 Individual-patient monitoring in clinical practice: Are available health status surveys adequate Qual Life Res 4 293 307
40. DA Sloan MB Donnely RW Schwartz JL Felts AV Blue WE Strodel 1996 The use of the objective structured clinical examination (OSCE) for evaluation and instruction in graduate medical education J Surg Res 63 225
41. GL Iverson 2001 Interpreting change on the WAIS-III/WMS-III in clinical samples Arch Clin Neuropsychol 16 183 191
42. B Middel R Stewart J Bouma 2001 How to validate clinically important change in health-related functional status. Is the magnitude of the effect size consistently related to magnitude of change as indicated by a global question rating? J Eval Clin Pract 7 4 399 410
43. GR Norman SF Gwadry GH Guyatt SD Walter 2001 Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life Med Care 39 10 1039 1047
44. GR Norman JA Sloan KW Wyrwich 2003 Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation Med Care 41 5 582 592 May
45. S Tofte M Graeber R, Cherill 1999 Eczema area and severity index (EASI): A new tool to evaluate atopic dermatitis J Eur Acad Dermatol Venereol 12 Suppl. 2 s140
46. JM Hanifin M Thurston M Omoto 2001 The eczema area and severity index (EASI): Assessment of reliability in atopic dermatitis Exp Dermatol 10 11 18
47. CR Touw L Kakkaart-Van Roijen P Verboom 2001 Quality of life and clinical outcome in psoriasis using intermittent cyclosporin Br J Dermatol 144 967 972
48. A Wahl C Burckhardt I Wiklund BR Hanestad 1998 The Norwegian version of the Quality of Life Scale (QOLS-N): A validation and reliability study in patients suffering from psoriasis Scand J Caring Sci 12 215 222
49. SP [tmp] McKenna D Whalley LC Doward 2000 Which outcomes are important in schizophrenia Int J Methods Psychiatr Res Suppl. 9 S58 S67
50. TR Parmenter 1994 Quality of life as a concept and measurable entity Soc Indicators Res 33 9 46
51. SP [tmp] McKenna SA Cook D Whalley 2003 Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials Br J Dermatol 149 323 331
52. EF Juniper GH Guyatt A Willan LE Griffith 1994 Determining a minimal important change in a disease-specific quality of life questionnaire J Clin Epidemiol 47 81 87
53. G Norman P Stratford G Regehr 1997 Methodological problems in the retrospective computation of responsiveness to change: The lessons of Cronbach J Clin Epidemiol 50 869 879
54. HF Van Stel AR Maille VT Colland W Everaerd 2003 Interpretation of change and longitudinal validity of the quality of life for respiratory illness questionnaire (QoLQIQ) in patient pulmonary rehabilitation Qual Life Res 12 133 145
55. KW Wyrwich VM Staebler Tardino 2003 Understanding global transition assessments Qual Life Res 12 7 733